Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 8785 - 8792 of 12085 results
On rail and highway mega-projects, practice makes perfect
January 7, 2016| News
Mintz 2nd Annual Employment Law Summit – ACA Reporting Requirements in Plain English
January 6, 2016| Blog| Viewpoint
New York City Establishes Office of Labor Standards; Will Enforce Paid Sick Leave Law (NYC Finale Part 3)
January 6, 2016| Blog| Viewpoint
Inside Counsel: Delay in Implementing Cadillac Tax Raises Questions on Health Insurance
January 6, 2016| Blog| Viewpoint
The Managed Care Industry – 2015 Year in Review
January 6, 2016| Blog| Viewpoint
Massachusetts Uses Telemedicine Technology to Expand Access to Behavioral Health Services
January 6, 2016| Blog| Viewpoint
Reminder - Biosimilars Webinars: A Five-Part Legal and Regulatory Issues Series
January 6, 2016| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|